Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endocrine problems in the menopause

C B Hammond, S J ory

    Clinical Obstetrics and Gynecology
    |March 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Menopause involves significant changes due to declining estradiol. Estrogen therapy helps symptoms like hot flashes but carries risks, including endometrial cancer, which can be mitigated with progestin.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    False positive hCG.

    Obstetrics and gynecology·2001
    Same author

    Prolonged inhibition of presynaptic catecholamine synthesis with alpha-methyl-para-tyrosine attenuates the circadian rhythm of human TSH secretion.

    Journal of the Society for Gynecologic Investigation·2001
    Same author

    HEDIS 2000: strategies for successful menopause management.

    The American journal of managed care·2001
    Same author

    Consequences of estrogen deprivation and the rationale for hormone replacement therapy.

    The American journal of managed care·2001
    Same author

    Multiple pregnancies: what action should we take?

    Fertility and sterility·2001
    Same author

    A comparison of post-thaw results between cryopreserved embryos derived from intracytoplasmic sperm injection and those from conventional IVF.

    Fertility and sterility·1999
    Same journal

    Obstetric Care for Patients With Cognitive Disabilities.

    Clinical obstetrics and gynecology·2026
    Same journal

    Dissecting the Americans With Disabilities Act (ADA) Requirements when Approaching Obstetric Patients With Disabilities: How to Ensure Your Spaces are Accessible for All.

    Clinical obstetrics and gynecology·2026
    Same journal

    Clinician Comfort and Barriers to the Obstetric and Gynecologic Care of Patients With Disabilities.

    Clinical obstetrics and gynecology·2026
    Same journal

    Obstetric Care for Patients With Visual Impairments: Preconception Counseling Through Postpartum Care.

    Clinical obstetrics and gynecology·2026
    Same journal

    Menstrual Management and Contraception for Patients With Disabilities.

    Clinical obstetrics and gynecology·2026
    Same journal

    Favoring Elective Hospitalization in Pregnancies With Vasa Previa.

    Clinical obstetrics and gynecology·2026
    See all related articles

    Area of Science:

    • Reproductive Endocrinology
    • Gerontology
    • Gynecologic Oncology

    Background:

    • The climacteric signifies a transition period marked by physiological, psychological, and sociological shifts.
    • A key factor is the decline in ovarian follicle function and estradiol production.
    • This estrogen deficiency leads to systemic changes impacting quality of life and potentially posing life-threatening risks.

    Purpose of the Study:

    • To review the effects of estrogen deficiency during the climacteric.
    • To evaluate the efficacy and risks of estrogen replacement therapy (ERT).
    • To discuss strategies for mitigating ERT-associated risks, particularly endometrial cancer.

    Main Methods:

    • Literature review of climacteric changes and estrogen replacement therapy.

    Related Experiment Videos

  • Analysis of systemic effects of estrogen deficiency.
  • Evaluation of risk factors and protective measures for ERT.

    • Main Results:

    • Estrogen replacement therapy effectively alleviates symptoms such as osteoporosis, vasomotor symptoms, and genital atrophy.
    • A significant risk associated with ERT is endometrial adenocarcinoma.
    • Patient selection, close monitoring, minimized exposure, and progestin addition can reduce this risk.

    Conclusions:

    • Estrogen deficiency during the climacteric necessitates careful management.
    • Estrogen replacement therapy offers benefits but requires risk mitigation strategies.
    • Further research on optimal dosage and agent selection is needed to enhance safety and reduce adverse reactions like endometrial cancer.